Evidence map›Paper›PMID 41491155›Full record

ArticleBlood cancer journal2026

Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data.

Yu-Sung Chang, Feng-Ming Tien, Yu-Wen Wang, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Sao-Chih Ni, Min-Yen Lo, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. EJHaem · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yu-Sung ChangDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0009-0000-4571-3328
Feng-Ming TienDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0003-4513-2472
Yu-Wen WangDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chi-Yuan YaoDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0001-5052-9445
Xavier Cheng-Hong TsaiDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Sao-Chih NiDepartment of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.ORCID http://orcid.org/0000-0001-6337-1448
Min-Yen LoDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
Wan-Hsuan LeeDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0003-4795-9844
Chien-Chin LinDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0001-7160-2285
Yuan-Yeh KuoTai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-6090-9000
Yen-Ling PengDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Mei-Hsuan TsengTai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.
Bor-Sheng KoDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-7965-7579
Ming YaoDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Hwei-Fang TienDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-1384-5593
Hsin-An HouDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw.ORCID http://orcid.org/0000-0003-2780-4845
Wen-Chien ChouDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.ORCID http://orcid.org/0000-0003-2967-698X

Funding

Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan) MOHW 107-TDU-B-211-114009Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan) MOHW 111-TDU-B-221-014001Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 111-2314-B-002-279Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 114-2314-B-002-256-MY3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41491155
PMCPMC12770354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.